<https://www.empr.com/home/news/drugs-in-the-pipeline/risankizumab-bla-submitted-for-moderate-to-severe-plaque-psoriasis/#primaryimage>
<http://schema.org/height>
<https://www.empr.com/home/news/drugs-in-the-pipeline/risankizumab-bla-submitted-for-moderate-to-severe-plaque-psoriasis/>